Trials / Unknown
UnknownNCT02561559
SBRT Treatment for Lung Metastasis From Soft Tissue Sarcoma
Phase II Study to Evaluate Feasibility and Safety of Stereotactic Body Radiation Radiotherapy (SBRT) for Lung Metastases From Soft Tissue Sarcoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 37 (actual)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
In this study the investigators treat PM oligometastatic patients with SBRT. Our objective is to evaluate rate of local control of treated lesions in patients treated with Intensity Modulated Radiation Therapy (IMRT) using Volumetric Modulated Arc Therapy (VMAT) for lung metastases from STS.
Detailed description
The investigators started to treat PM oligometastatic patients with Stereotactic Body Radiotherapy. The investigators objective is to evaluate rate of local control of treated lesions in patients treated with Intensity Modulated Radiation Therapy (IMRT) using Volumetric Modulated Arc Therapy (VMAT) for lung metastases from soft-tissue sarcomas. Overall and disease free survival will be evaluated as secondary endpoints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Lung metastasis from soft-tissue sarcoma | Tretament based on Intensity Modulated Radiation Therapy (IMRT) using Volumetric Modulated Arc Therapy (VMAT) |
Timeline
- Start date
- 2015-06-10
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2015-09-28
- Last updated
- 2022-05-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02561559. Inclusion in this directory is not an endorsement.